<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Document</title>
</head>
<body>
    <h4>BUSINESS MODEL</h4>
    <p>The Indian Pharmaceutical Market (IPM) is the largest business unit forMerva lifesciences pvt ltd which is operated under merva 
        Despite being a late entrant in the market, merva  has leapfrogged its peers and established itself as a leading player with a niche product basket and positioning.
        Merva  portfolio is focused towards pharmaceutical products used in chronic (including sub-chronic) therapeutic areas. We are the largest pharmaceutical company in the gynecology and human immunodeficiency virus  antivirals therapeutic areas in India in terms of Domestic Sales for MAT September 2023.
        merva has been gynaecology  products consistently for the past three years. Merva  domestic business has always been driven by technology-based innovation having launched multiple first to market launches including Hamsyl, Elaxim, Ferium XT, Instgra, Encicarb through innovations in the concepts of chirality, complex molecules, iron compounds and injectables.
        </p>
        <p>Mastering Complex Generics
            Merva life sciences pvt ltd  specialises in developing complex generic formulations across various dosage forms, including ophthalmic, injectable, sterile,  and nasal products veterinary products bolus, veterinary injectables, feed suppliments and nutraceuticals and gummies.
            
            Our advanced formulation development  facility ensures compliance with regulatory standards, supporting product development from start to finish. Weâ€™ve launched branded products in key therapeutic areas to meet the needs of a broader patient base.
            </p>
            <h4>Quality byExcellence</h4>
            <p>MERVALIFESCIENCES , the pursuit of quality is an unceasing journey towards a mature establishment and evolving milestones. The QbX Programme exemplifies this commitment. The key focus areas ARE FOLLOWING 
                Regulatory Compliances
                Increasing People Competencies
                Developing Lean Laboratory Concepts
                Process Enhancement
                Documentation Simplification
                Productivity Enhancement
                Compliance &
                Regulatory
                Our commitment to quality is enforced through stringent adherence to international and national regulatory standards. Mankind Pharma is dedicated to ensuring that all our processes and products meet the rigorous safety, quality, and efficacy standards.
                </p>
                <p>Merva Life sciences is an integrated contract manufacturer of Non beta Sterile injectables (Dry/ Liquid), Non beta Tablets and Capsules.
                    Leading contract manufacturer of Clinical to Commercial Sterile injectables.
                    Serving global leaders in pharmaceutical industries.
                    Offering key services including full testing, regulatory support, customize secondary packaging and stability.
                    </p>
</body>
</html>